Litcius/Paper detail

Cryptotanshinone ameliorates CUS-induced depressive-like behaviors in mice

Kaixin Wang, Qingling Zhai, Sanwang Wang, Qiongyu Li, Jing Liu, Fantao Meng, Wentao Wang, Jinjie Zhang, Dan Wang, Di Zhao, Cuilan Liu, Juanjuan Dai, Chen Li, Minghu Cui, Jinbo Chen

2021Translational Neuroscience17 citationsDOIOpen Access PDF

Abstract

OBJECTIVES: , has shown various pharmacological properties. However, its effect on chronic unpredictable stress (CUS)-induced depression phenotypes and the underlying mechanism remain unclear. Therefore, the aim of this study was to investigate whether CPT could exert an antidepressant effect. METHODS: We investigated the effects of CPT in a CUS-induced depression model and explored whether these effects were related to the anti-inflammatory and neurogenesis promoting properties by investigating the expression levels of various signaling molecules at the mRNA and protein levels. RESULTS: Administration of CPT improved depression-like behaviors in CUS-induced mice. CPT administration increased the levels of doublecortin-positive cells and reversed the decrease in the expression levels of brain-derived neurotrophic factor (BDNF)/tyrosine kinase receptor B (TrkB) signaling transduction, as well as the downstream functional proteins, phosphorylated extracellular regulated protein kinases (p-ERK), and cyclic adenosine monophosphate (cAMP)-response element-binding protein levels (p-CREB) in hippocampus. CPT treatment also inhibited the activation of microglia and suppressed M1 microglial polarization, while promoting M2 microglial polarization by monitoring the expression levels of arginase 1 (Arg-1) and inducible nitric oxide synthase (iNOS), and further inhibited the expression of proinflammatory cytokines, including interleukin (IL)-1, IL-6, and tumor necrosis factor-α (TNF-α), and increased the expression of the anti-inflammatory cytokine IL-10 by regulating nuclear factor-κB (NF-κB) activation. CONCLUSIONS: CPT relieves the depressive-like state in CUS-induced mice by enhancing neurogenesis and inhibiting inflammation through the BDNF/TrkB and NF-κB pathways and could therefore serve as a promising candidate for the treatment of depression.

Topics & Concepts

CREBProinflammatory cytokineTropomyosin receptor kinase BNeurotrophic factorsBrain-derived neurotrophic factorSignal transductionChemistryTumor necrosis factor alphaNeurogenesisMAPK/ERK pathwayCyclic adenosine monophosphateKinasePharmacologyEndocrinologyInternal medicineInflammationCell biologyBiologyReceptorMedicineTranscription factorBiochemistryGeneTryptophan and brain disordersNeuroinflammation and Neurodegeneration MechanismsTreatment of Major Depression
Cryptotanshinone ameliorates CUS-induced depressive-like behaviors in mice | Litcius